Crinetics Pharmaceuticals, Inc. (CRNX)
37.00
-0.09
(-0.24%)
USD |
NASDAQ |
May 22, 13:37
Crinetics Pharmaceuticals EPS Diluted (Quarterly) : -1.228 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | 0.1893 |
| Aquestive Therapeutics, Inc. | -0.0657 |
| Merck & Co., Inc. | -1.715 |
| Nektar Therapeutics | -1.815 |
| Prestige Consumer Healthcare, Inc. | 1.131 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -127.84M |
| Revenue (Quarterly) | 10.73M |
| Total Expenses (Quarterly) | 138.58M |
| Enterprise Value | 2.667B |
| Gross Profit Margin (Quarterly) | 87.33% |
| Profit Margin (Quarterly) | -1.19K% |
| Earnings Yield | -13.87% |
| Normalized Earnings Yield | -13.87 |